Pharma growth: AstraZeneca profit surges 77% to $2.53 bn in Q3; US expansion and cancer drugs power strong results
AstraZeneca reported a significant 77% surge in quarterly net profit, reaching $2.53 billion, driven by strong US growth and robust sales of its cancer drugs. The pharmaceutical giant’s revenue climbed 12% to $15.2 billion, with oncology treatments now comprising nearly 44% of its total income. This performance underscores the company’s strategic focus on expanding its US operations and manufacturing footprint.🕒 1 min read
AstraZeneca reported a significant 77% surge in quarterly net profit, reaching $2.53 billion, driven by strong US growth and robust sales of its cancer drugs. The pharmaceutical giant’s revenue climbed 12% to $15.2 billion, with oncology treatments now comprising nearly 44% of its total income. This performance underscores the company’s strategic focus on expanding its US operations and manufacturing footprint.
Continue Reading
- 3 Vitamin Deficiencies That Lead To Premature Hair Greying
-
“Epstein Told Me His Darkest Secrets”: Survivor Recalls Once Silenced Horror
-
IND vs ENG: Karun Nair – ‘A prominent Indian cricketer advised me to retire’
-
Ownership Changes To Impact RCB’s Fortunes? Ex-India Star Makes Big Prediction
- Indian aviation set to grow by 10% by FY2026, but financial losses likely to persist: ICRA report
- Middle East crisis may be over, but how long before Strait of Hormuz goes back to normal?
-
Centre tags coking coal as critical & strategic mineral to drive self-reliance in steel sector
-
Can A Shot Of Olive Oil Help Relieve Chronic Inflammation? Here’s What You Should Know
- Who Is Kirti Patel, Influencer Arrested For Honeytrapping Gujarat Builder
- IPL Live: Mohsin Khan strikes early as KKR lose Tim Seifert